Q09488 AF NFT

Serine/threonine-protein kinase receptor sma-6

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeickcyugogww4d5btbsmq7cn5x4mau7vaopj7mbfy3uq7wzyht5eqa/metadata.json
IPFS of structure file: 
bafybeih3fywjtr5lja5giah6yj7rxaibnbspgqeqevne2xwugsbuu4sp2m/AF-Q09488-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xe98bf0c02d2A46E3299A9930210B6C72162719bF
First NFT owner address (bech32): 
genesis1ax9lpspd9frwx2v6nyczzzmvwgtzwxdl6avkay
Current NFT ID #430725 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
430725
Accession (UniProt):
Q09488
Name::
Serine/threonine-protein kinase receptor sma-6
Experimental Method:
Predicted structure
Sequence source:
CAENORHABDITIS ELEGANS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q09488 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q09488|SMA6_CAEEL Serine/threonine-protein kinase receptor sma-6 OS=Caenorhabditis elegans OX=6239 GN=sma-6 PE=1 SV=1 MNITFIFILIFGFFNTQKCSKDYDHFDDEDLALSIPKNAIGVPKEFRQQVLKEMKLRNRPNDILKNRCYCNYDQSICGNNMTCVKQDGAACYHAVEEVYNKAEKRMETLHKWGCATLERGSGASHLTCNSWRAAHHSPKSIGCCYEGNYCNKNLIPPAYVHHHKEKALQEKTDNPEDYDSPLENMTRGGKMFIMVFATVMSVFAVIGCIYLCITRAEEKSKARARAKTVSLKTESTYMESKSMLEDSGSGSGQAALIQRTVRQDLTIIKTIGQGRYGEVRKALYRGSYVAVKTFYTTDEDSWKNERDVYQTNMINHENILQFVAADIWSEEDSMTKMLLITDYHELGSLSDYLCREETLTTDEALRLIHSCICGIEHLHAAVHGTGSFRKPEIAHRDIKSKNIIVKRPNVCCIADLGLALRYQNDKILPEKFNVQVGTKRYMAPELISNKLNPKDFSQFKMADIYSMALVMWEVAIRVEVNTCEEVLTVDETSPDHSASSGIGESVSSSGNISRMHLQKTNVEGHSTSLKAKQHVPPFDGIVHNDPNFDEMNDVICVRRIRPPPDLAWKNVPALNELSKLMEDSWHSIPHFRHSALKLKKEMAELIKNPDRQNQSQRKVEFQQQDSGLVESATNQS